The sulfoglycolipids sulfoquinovosylacylglycerols(SQAG) are abundant sulfur-containing glycerolipids that are associated with photosynthetic organisms especially with a large number of marine algae. Their main structural feature is the anionic head group constituent sulfoquinovose, a derivative of glucose in which the 6-hydroxyl is replaced by a sulfonate group, -linked to the sn-3 position of a diacylglycerol1. Recently reported biological activities of SQAGs, including inhibitory effects on HIV-reverse transcriptase, and mammalian DNA polymerase, proliferation of some cancer cell lines, angiogenesis (especially when coupled with tumor radiotherapy), and apoptosis induction, make these compounds very attractive for their potential in cancer therapy. Also, extractive SQAG mixtures are known to inhibit in vitro TPA induced tumor promotion stage. To obtain new active compounds for cancer therapy by structural modification of natural SQAGs, SQAG analogues have been synthesized in which the sulfoquinovose moiety is linked to the 2 position of glycerol carrying acyl chains of different length. Similar compounds in fact, with a 6’-hydroxyl instead of a 6’-sulfonate (namely some glycoglycerolipid analogues), are known to be active as anti-tumor-promoters in TPA promoted carcinogenesis in vitro and in vivo experiments. A synthetic strategy has been used to selectively insert the proper chemical functionalities (i.e. sulfonate and acyl chains) at the desired positions of the previously prepared glucosylglycerol skeleton to obtain the target compounds. Biological evaluation of anti-tumor activities will be performed including the study of their chemopreventing potential.

Sulfoglycolipids analogues as new molecules for tumor treatment / M. Dangate, D. Colombo, L. Franchini, F. Ronchetti. ((Intervento presentato al 11. convegno Congress school on carbohydrate chemistry tenutosi a Pontignano nel 2008.

Sulfoglycolipids analogues as new molecules for tumor treatment

M. Dangate
Primo
;
D. Colombo
Secondo
;
L. Franchini
Penultimo
;
F. Ronchetti
Ultimo
2008

Abstract

The sulfoglycolipids sulfoquinovosylacylglycerols(SQAG) are abundant sulfur-containing glycerolipids that are associated with photosynthetic organisms especially with a large number of marine algae. Their main structural feature is the anionic head group constituent sulfoquinovose, a derivative of glucose in which the 6-hydroxyl is replaced by a sulfonate group, -linked to the sn-3 position of a diacylglycerol1. Recently reported biological activities of SQAGs, including inhibitory effects on HIV-reverse transcriptase, and mammalian DNA polymerase, proliferation of some cancer cell lines, angiogenesis (especially when coupled with tumor radiotherapy), and apoptosis induction, make these compounds very attractive for their potential in cancer therapy. Also, extractive SQAG mixtures are known to inhibit in vitro TPA induced tumor promotion stage. To obtain new active compounds for cancer therapy by structural modification of natural SQAGs, SQAG analogues have been synthesized in which the sulfoquinovose moiety is linked to the 2 position of glycerol carrying acyl chains of different length. Similar compounds in fact, with a 6’-hydroxyl instead of a 6’-sulfonate (namely some glycoglycerolipid analogues), are known to be active as anti-tumor-promoters in TPA promoted carcinogenesis in vitro and in vivo experiments. A synthetic strategy has been used to selectively insert the proper chemical functionalities (i.e. sulfonate and acyl chains) at the desired positions of the previously prepared glucosylglycerol skeleton to obtain the target compounds. Biological evaluation of anti-tumor activities will be performed including the study of their chemopreventing potential.
22-giu-2008
Sulfoglycolipids analogues as new molecules for tumor treatment / M. Dangate, D. Colombo, L. Franchini, F. Ronchetti. ((Intervento presentato al 11. convegno Congress school on carbohydrate chemistry tenutosi a Pontignano nel 2008.
Conference Object
File in questo prodotto:
File Dimensione Formato  
abstract sienna.doc

accesso aperto

Tipologia: Pre-print (manoscritto inviato all'editore)
Dimensione 113.5 kB
Formato Microsoft Word
113.5 kB Microsoft Word Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/71927
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact